20200912 Professor Thomas Borody Interview - Part 1
What is the recommended ivermectin-based tri-therapy
How is this early therapy administered to old and younger people alike
Examples of elderly people “turning the corner” after being treated
The increasing adoption of the tri-therapy in Australia
Note in Australia and other parts of the world a similar Triple Therapy involving Hydroxychloroquine (HCQ) is banned.
In the Invermectin-based tri-therapy and the Hydroxychloroquine based tri-therapy, it is the Zinc that does the worl to prevent the virus replication stage in the cell - the Invermectin and the Hydroxychloroquine act as the Ionophore for zinc to get it across the cell membrane and to let it block the virus replication.
Professor Thomas Borody is a world renowned medical doctor from Australia with over 40 years experience in clinical research and practice, including at the St Vincent Hospital in Sydney and at the Mayo clinic in the US.
Some of his most ground breaking contributions in medical science include the development of a tritherapy for peptic ulcers, the development of faecal microbiota transplants for colitis and other diseases, and recently, a therapy for Crohn disease.
In 1984 he established the Centre for Digestive Diseases in Sydney. He oversaw its growth into an active clinical research institute with 65 employees.
Professor Borody has published numerous articles and is a reviewer for leading international medical journals.
With the pandemic, Professor Borody took a particular interest in researching a therapy for COVID-19, and this is what this interview is all about.
This may be an excellent work around the Political (not science) blocked HCQ treatment until the overwhelming HCQ evidence forces Politicians; their experts, and the complicit Mainstream Media to accept and allow the free passage of HCQ based therapies to do its work; save lives.
Please sign this petition to let Australian Doctors Prescribe HCQ
http://tribeqr.com/v/hcqpetition
Please then post it to your facebook from the petition page
How is this early therapy administered to old and younger people alike
Examples of elderly people “turning the corner” after being treated
The increasing adoption of the tri-therapy in Australia
Note in Australia and other parts of the world a similar Triple Therapy involving Hydroxychloroquine (HCQ) is banned.
In the Invermectin-based tri-therapy and the Hydroxychloroquine based tri-therapy, it is the Zinc that does the worl to prevent the virus replication stage in the cell - the Invermectin and the Hydroxychloroquine act as the Ionophore for zinc to get it across the cell membrane and to let it block the virus replication.
Professor Thomas Borody is a world renowned medical doctor from Australia with over 40 years experience in clinical research and practice, including at the St Vincent Hospital in Sydney and at the Mayo clinic in the US.
Some of his most ground breaking contributions in medical science include the development of a tritherapy for peptic ulcers, the development of faecal microbiota transplants for colitis and other diseases, and recently, a therapy for Crohn disease.
In 1984 he established the Centre for Digestive Diseases in Sydney. He oversaw its growth into an active clinical research institute with 65 employees.
Professor Borody has published numerous articles and is a reviewer for leading international medical journals.
With the pandemic, Professor Borody took a particular interest in researching a therapy for COVID-19, and this is what this interview is all about.
This may be an excellent work around the Political (not science) blocked HCQ treatment until the overwhelming HCQ evidence forces Politicians; their experts, and the complicit Mainstream Media to accept and allow the free passage of HCQ based therapies to do its work; save lives.
Please sign this petition to let Australian Doctors Prescribe HCQ
http://tribeqr.com/v/hcqpetition
Please then post it to your facebook from the petition page